Global Cancer Photodynamic Therapy Market and Cancer Photosensitisers Clinical Trial Outlook 2023

For Report Sample Contact: neeraj@kuickresearch.com

 

Report Weblink: https://www.kuickresearch.com/report-global-cancer-photodynamic-therapy-market-and-cancer-photosensitisers-clinical-trial-outlook-2023.php

 

Table of Contents

 

1. An Introductory Insight into Photodynamic Cancer Therapy

    1.1 Overview

    1.2 History and Evolution of the Photodynamic Cancer Therapy

2. Photodynamic Therapy andndash; A Breakthrough in Modern Cancer Therapy

  2.1 Dire Need for Photodynamic Therapy in Cancer Treatment andndash; An Insight into its promising features

  2.2 Superiority of Photodynamic Cancer Therapy over Traditional Cancer Therapy Method

3. Working Mechanism of the Photodynamic Cancer Therapy- It’s Components and Their Role

  3.1 Procedure for Photodynamic Therapy

  3.2 Photosensitizers (PS) andndash; A Crucial Component of the Photodynamic Therapy

    3.2.1 Classification of Photosensitizers

    3.2.2 Desired Features of an Effective Photosensitizer Agent

    3.2.3 Photosensitizers Currently Used in Photodynamic Therapy

  3.3 Oxygen – The Vital Substrate in Photodynamic Therapy

  3.4 Light Source – For Safe and Effective Activation of the Photosensitizer

4. Photosensitizer Delivery andndash; For Increased Efficacy of the Photdynamic Therapy

  4.1 Organic Nano Particles Photosensitizer Delivery in Photo Dynamic therapy

  4.2 Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy

5. Anti-Tumor Activity of the Photodynamic Therapy

  5.1 Direct Tumor Photodynamic Therapy Damage

  5.2 Vascular Damage

  5.3 Inflammatory and Immune Response

6. Current Status of Various Cancer Treatments Using Photodynamic Therapy

  6.1 Non-Melanoma Skin Cancer

  6.2 Prostate Cancer

  6.3 Breast Cancer

  6.4 Brain Tumor

  6.5 Lung Cancer

  6.6 Head and Neck Cancer

  6.7 Oral Lesions and Oesophageal Cancer

  6.8 Cervical Cancer

  6.9 Colorectal Cancer

  6.10 Cancer of the Bile Duct and the Pancreas

7. Photodynamic Combinational Cancer Therapy- Overcoming Current Cancer Therapy Limitations

8. Recent and Promising Advances in the Photodynamic Therapy Segment

  8.1 Intracellular “Activated” Two-Photon photodynamic Therapy for Breast Cancer

  8.2 Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.

  8.3 Photodynamic Therapy and Combinational Therapy using Microbial Adjuvants and Cytokines

9. Current Market Scenario of the Photodynamic Therapy and its Cognizance in the Oncology Segment

  9.1 Global Photodynamic Therapy Market Analysis by Device and Essentials

  9.2 Regional Analysis of the Photodynamic Therapy Market

    9.2.1 North America

    9.2.2 Europe

    9.2.3 Asia Pacific

    9.2.4 Latin America, Middle East and Africa

10. Favorable Factors for the Growth of Photodynamic Cancer Therapy Market

  10.1 Rise in Global Cancer Incident

  10.2 Increasing Awareness Regarding Photodynamic Therapy

  10.3 Limitations and Failures of Existing Cancer Therapeutics

  10.4 Advancement in Research and Development

  10.5 Increasing Investment in the Photodynamic Therapy Segment

  10.6 Presence of a Strong Clinical Pipeline

  10.7 Approvals of the FDA

11. Challenges to the Photodynamic Therapy Market Growth

  11.1 Technical and Scientific Limitations

  11.2 Dominance of Conventional Therapeutics

  11.3 Commercial Challenges

  11.4 Patient Specific Issues

  11.5 Side Effects Associated with the Photodynamic Therapy

12. Anticipation Regarding the Future of Photodynamic Cancer Therapy

13. Global Cancer Photosensitisers Clinical Pipeline by Company and Phase

  13.1 Preclinical

  13.2 Phase-I

  13.3 Phase-I/II

  13.4 Phase-II

  13.5 Phase-III

  13.6 Registered

14. Marketed Cancer Photosensitisers Clinical Pipeline by Company

  14.1 Hexyl Aminolevulinate (Cevira, Cysview, Hexvix and Hexvix PDT)

  14.2 Methyl Aminolevulinate (Metvix, Metvix PDT, Metvixia and Visonac)

  14.3 Talaporfin (Aptocine, Aptocine, Aptocine and Litx)

  14.4 Aminolevulinic Acid (Litx and Alaglio)

  14.5 Aminolevulinic Acid (Alaglio, Effala, Gleolan and Gliolan)

  14.6 Porfimer Sodium (Photobarr, Photofrin, Photofrin II and Photofrin PDT)

  14.7 Methoxsalen Solution (UVADEX)

  14.8 Temoporfin (Foscan)

15. Competitive Landscape

  15.1 Theralase Technologies

  15.2 Dusa Pharmaceuticals

  15.3 Biofrontera AG

  15.4 Soligenix

  15.5 Coherent

  15.6 Lumenis

  15.7 Nanoprobes

  15.8 PhotoMedex

  15.9 Biolitec

  15.10 Ambicare Health

  15.11 Quest Pharma Tech

  15.12 Photolitec

 

Figure 1-1: Evolution of Photodynamic Therapy

Figure 2-1: The Need for Cancer Photodynamic Therapy

Figure 2-2: Superiority of Cancer Photodynamic Therapy over Other Methods

Figure 3-1: Working Principle of Photodynamic Therapy

Figure 3-2: Desired Features of an Ideal Photosensitizer

Figure 3-3: Cellular Mechanism of Photodynamic Therapy

Figure 3-4: Various Types of Light Sources Used in Photodynamic Therapy

Figure 4-1: Drug Carriers for Photodynamic Therapy

Figure 4-2: Delivery of Photosensitizer Drugs Using Liposomes

Figure 4-3: Structure of a Quantum Dot

Figure 4-4: Gold Nanoparticles for Targeted Delivery of Photosensitizers

Figure 5-1: Apoptosis of Tumor Cell Induced by Photodynamic Therapy

Figure 5-2: Vascular Damage of Tumor Cells Induced By Photodynamic Cancer Therapy

Figure 5-3: Tumor Cell Death Pathways by Reactive Oxygen Species

Figure 6-1: Photodynamic Therapy for Lung Cancer

Figure 6-2: Photodynamic Therapy for the treatment of Cervical Cancer

Figure 7-1: Limitation of Cancer Photodynamic Therapy

Figure 9-1: Use of Photodynamic Therapy for Various Skin Cancer Types

Figure 9-2: Global andndash; Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2017-2023

Figure 9-3: Global – Cancer Photodynamic Therapy Shares by Devices and Essentials

Figure 9-4: Global andndash; Cancer Photosensitisers Clinical Pipeline by Phase (%), 2017 till 2023

Figure 9-5: Global – Photosensitisers Clinical Pipeline by Phase (Number), 2017 till 2023

Figure 9-6: Global andndash; Cancer Photosensitisers Clinical Pipeline by Phase (%), 2017 till 2023

Figure 9-7: Global andndash; Cancer Photosensitisers Clinical Pipeline by Phase (Number), 2017 till 2023

Figure 10-1: Global – Driving Factors of the Cancer Photodynamic Therapy Market

Figure 10-2: Global – Breast, Lung and Skin Cancer Statistics, 2013-2016

Figure 11-1: Global andndash; Cancer Photodynamic Therapy Market Challenges

Figure 11-2: Global – Scientific Limitations of the Cancer Photodynamic therapy

Figure 11-3: Global – Commercial Challenges to the Photodynamic Therapy Market

Figure 12-1: Global – Future Governing Factors of the Photodynamic Therapy Market